A groundbreaking AI system, Delphi-2M, predicts disease risks up to 20 years in advance by analyzing extensive medical records from over 40,000 Biobank participants and 1.9 million Danish health records. Developed by a team from the German Cancer Research Center, the University of Copenhagen, and the European Molecular Biology Laboratory, this innovative tool forecasts the progression of over 1,000 diseases, including type 2 diabetes and heart attacks. Published in Nature, the AI’s ability to identify high-risk individuals allows for early interventions, promoting better health outcomes. Its transformer-based model excels in predicting and understanding personalized health risks, serving as a powerful asset for precision medicine. While acknowledging AI’s environmental challenges, researchers emphasize its potential in addressing pressing global issues. Future tests for Delphi-2M will expand across diverse populations, aiming for clinical application soon. The findings offer hope for lifestyle modifications to combat disease progression. Stay updated with innovations reshaping our future!
Source link
Share
Read more